Total Payments
$87,666
2024 Payments
$1,872
Companies
58
Transactions
1,034
Medicare Patients
29,823
Medicare Billing
$2.5M
Payment Breakdown by Category
Other$69,096 (78.8%)
Food & Beverage$16,587 (18.9%)
Travel$1,920 (2.2%)
Education$62.96 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $69,096 | 39 | 78.8% |
| Food and Beverage | $16,587 | 962 | 18.9% |
| Travel and Lodging | $1,920 | 27 | 2.2% |
| Education | $62.96 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $61,791 | 108 | $0 (2020) |
| ABBVIE INC. | $11,515 | 48 | $0 (2024) |
| Lilly USA, LLC | $2,348 | 141 | $0 (2024) |
| Novo Nordisk Inc | $2,033 | 142 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,128 | 71 | $0 (2024) |
| Amgen Inc. | $1,063 | 71 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $749.04 | 45 | $0 (2024) |
| Corcept Therapeutics | $748.45 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $737.11 | 55 | $0 (2024) |
| Mannkind Corporation | $521.44 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,872 | 102 | Lilly USA, LLC ($428.32) |
| 2023 | $2,454 | 129 | Lilly USA, LLC ($496.38) |
| 2022 | $628.57 | 33 | Lilly USA, LLC ($104.29) |
| 2021 | $3,438 | 112 | AbbVie Inc. ($1,813) |
| 2020 | $5,020 | 90 | Janssen Pharmaceuticals, Inc ($2,793) |
| 2019 | $25,878 | 195 | Janssen Pharmaceuticals, Inc ($21,683) |
| 2018 | $28,281 | 194 | Janssen Pharmaceuticals, Inc ($22,485) |
| 2017 | $20,094 | 179 | Janssen Pharmaceuticals, Inc ($14,829) |
All Payment Transactions
1,034 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | CRENESSITY (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Obesity | ||||||
| 12/10/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Automated insulin delivery system | ||||||
| 12/04/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Durable Pump | ||||||
| 12/03/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: ENDOCRINE AGENT | ||||||
| 11/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Diabetes Care | ||||||
| 11/07/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $16.57 | General |
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $22.46 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Obesity | ||||||
| 10/18/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Endocrinology | ||||||
| 10/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: ENDOCRINE AGENT | ||||||
| 10/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 5,278 | 26,425 | $1.4M | $569,804 |
| 2022 | 36 | 5,545 | 26,920 | $1.5M | $560,318 |
| 2021 | 47 | 8,997 | 33,648 | $1.9M | $662,058 |
| 2020 | 54 | 10,003 | 35,906 | $2.1M | $660,898 |
Total Patients
29,823
Total Services
122,899
Medicare Billing
$2.5M
Procedure Codes
173
All Medicare Procedures & Services
173 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 198 | 19,321 | $581,491 | $352,680 | 60.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 316 | 498 | $97,608 | $42,922 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 507 | 651 | $87,885 | $38,648 | 44.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 133 | $34,580 | $17,211 | 49.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 208 | 214 | $70,885 | $15,349 | 21.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 323 | 411 | $61,650 | $11,854 | 19.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 309 | 309 | $115,875 | $11,167 | 9.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 432 | 678 | $61,020 | $11,091 | 18.2% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 218 | 270 | $50,760 | $10,922 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $26,048 | $10,233 | 39.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 650 | 1,027 | $20,540 | $8,621 | 42.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 425 | 658 | $51,982 | $5,778 | 11.1% |
| 78070 | Nuclear medicine study of parathyroid | Office | 2023 | 22 | 22 | $10,450 | $4,486 | 42.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 208 | 378 | $15,120 | $3,634 | 24.0% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 134 | 215 | $24,725 | $3,521 | 14.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 249 | 317 | $24,409 | $3,272 | 13.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 160 | 274 | $17,810 | $2,589 | 14.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 192 | 237 | $13,983 | $1,959 | 14.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 22 | 22 | $3,850 | $1,936 | 50.3% |
| 77081 | Dxa bone density measurement of forearm, finger, hand, or foot | Office | 2023 | 54 | 54 | $11,826 | $1,593 | 13.5% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 15 | 15 | $5,550 | $1,543 | 27.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 83 | 106 | $10,070 | $1,378 | 13.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 31 | 52 | $6,656 | $1,315 | 19.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 24 | $1,920 | $835.51 | 43.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,145 | $779.80 | 36.4% |
About Dr. Brooks Mays, MD
Dr. Brooks Mays, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Southern Pines, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124134010.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brooks Mays, MD has received a total of $87,666 in payments from pharmaceutical and medical device companies, with $1,872 received in 2024. These payments were reported across 1,034 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($69,096).
As a Medicare-enrolled provider, Mays has provided services to 29,823 Medicare beneficiaries, totaling 122,899 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 173 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Southern Pines, NC
- Active Since 08/22/2006
- Last Updated 03/17/2022
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1124134010
Products in Payments
- INVOKANA (Drug) $61,713
- Synthroid (Drug) $7,659
- SYNTHROID (Drug) $2,813
- JARDIANCE (Drug) $1,226
- Androgel (Drug) $952.24
- Ozempic (Drug) $867.07
- Korlym (Drug) $748.45
- FARXIGA (Drug) $737.11
- EVENITY (Biological) $547.47
- AFREZZA (Drug) $521.44
- Omnipod (Device) $514.08
- MOUNJARO (Drug) $512.92
- HUMULIN (Drug) $461.07
- TOUJEO (Drug) $406.15
- SOLIQUA 100/33 (Biological) $379.42
- Prolia (Biological) $362.53
- Minimed 670G System (Device) $278.52
- Horizant (Drug) $266.43
- Victoza (Drug) $259.66
- V-GO (Device) $253.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.